Ascendis Pharma A/S
Latest round
- Series D
Last raised
- Dec 2014
Total raised
- $96M
Investors
- 11
About Ascendis Pharma A/S
Ascendis Pharma A/S specializes in biopharmaceutical development.Ascendis Pharma specializes in the development of innovative biopharmaceuticals utilizing its proprietary TransCon™ technology platform. The company's core product offerings include therapies designed to address unmet medical needs in the fields of endocrinology, rare diseases, and oncology. Notably, Ascendis Pharma's flagship products, such as TransCon hGH for growth hormone deficiency and TransCon PTH for hypoparathyroidism, are engineered to enhance treatment safety and efficacy while improving patient convenience and tolerability.54 mn in 2024.22 mn in the same year. The company plans to launch new products targeting unmet needs in the market, particularly in endocrinology and rare diseases. Additionally, it is focused on expanding its market reach into Europe and other regions by the end of 2025.
Who invested in Ascendis Pharma A/S
11 investors across 3 rounds
See all investors in Ascendis Pharma A/S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ascendis Pharma A/S
Who invested in Ascendis Pharma A/S?
Ascendis Pharma A/S has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ascendis Pharma A/S raised?
Ascendis Pharma A/S has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ascendis Pharma A/S last raise money?
Ascendis Pharma A/S's most recent round on record is a Series D, in Dec 2014.
What does Ascendis Pharma A/S do?
Ascendis Pharma A/S specializes in biopharmaceutical development.
Where is Ascendis Pharma A/S headquartered?
Ascendis Pharma A/S is headquartered in Denmark.
Which VCs invest in companies like Ascendis Pharma A/S?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Ascendis Pharma A/S's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Ascendis Pharma A/S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.